todays, the parent company has a great role in managing and monitoring subsidiaries and companies in promoting their industrial activities. but, the main problem for pharmaceutical parent companies is the lack of clarity and confusion of responsibilities between units. successful parenting needs to create the element of 'fit' between the ways parent operates – parent characteristics –...

Phenytoin (pulverized powder), mefenamic acid (capsule), and sulpiride (film-coated tablet) are currently available on the Japanese market. For absorption of these drugs from their pharmaceutical preparations, they must disintegrate and dissolve during passage through the gastrointestinal tract. The bioavailability of these drugs differ among different pharmaceutical preparations and even for t...

The pharmaceutical market has some unique specifications in healthcare economics. It has to provide its products to the health systems and usually has to get its profits from reimbursement systems. But both health and reimbursement markets are rather different from free markets in terms of their official rules and being categorized as “market failure”. In such conditions, the first thought that...

INTRODUCTION Imagine that CureCo, Inc., is the exclusive seller of a patented product that yields hundreds of millions of dollars per year in revenues. CopyCo International announces its intention to market the product and compete with CureCo. CureCo promptly sues CopyCo for patent infringement. A federal court holds that the patent is invalid, appearing to clear the way for CopyCo to enter the...

Pharmaceutical companies are regarded as principal contributors to national economies all over the world owing to their substantial assistance to public health system; GDP, employment, and market growth. Consequently, pharmaceutical managers must take the necessary steps to improve strategy-making and firm performance. This study investigates the relationship between four conventional modes of ...

Previously published research by two of the authors found that returns on R&D for drugs introduced into the market in the 1970s and 1980s were highly skewed and that the top decile of new drugs accounted for close to half the overall market value. In the 1990s, there have been significant changes to the R&D environment for new medicines: the rapid growth of managed care organizations; indicatio...

PURPOSE The goal of this study was to build basic information related to the production and market of human vaccine products in Korea, which can be an important indicator to provide basic data in practical use. MATERIALS AND METHODS Statistical data were obtained from the Bank of Korea, Korea Health Industry Development Institute, Korea Pharmaceutical Traders Association, and Korea Pharmaceut...

Our study devotes special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study how the timing to engage in R&D cooperations in the pharmaceutical industry impacts firms performance in technology and product markets. Using a comprehensive dataset on the pharmaceutical industry, and estimating a...

IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine) is a nonprofit organization with the mission to promote Pharmaceutical Medicine & Medicines Development (PM&MD) by enhancing the competencies and maintaining high research ethical standards of Pharmaceutical Physicians and other professionals involved in medicines development worldwide, lea...